fqubed logo
left bar array of vials
If you are interested in more information about fqubed’s proprietary high throughput experimentation platforms for screening how formulations affect the skin, or are interested in applications of fqubed’s proprietary multiplexed molecular penetration enhancer (“MMPE™”) formulations platform, please send an email to info@fqubed.com.
From 2006 fqubed, Inc. has been a wholly-owned subsidiary of Nuvo Research Inc.
Nuvo's home page